Fierce Pharma

OCTOBER 8, 2024

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.” In declaring the end of the shortage, the FDA has halted the ability of compounding pharmacies to manufacture the in-demand products.

FDA 322

FDA Manufacturing 322

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

145

145

Fierce Pharma

OCTOBER 8, 2024

Editor's Note: Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub in Tampa, Florida, in 2021—is setting out to bolster emergency services, pool donations and ease medical supply needs as Hurricane Milton touches down this week.

Medical 307

Medical 307

MedCity News

OCTOBER 8, 2024

The best solutions, in summary, are those that facilitate better outcomes while reducing costs — combining member health and satisfaction with healthcare savings. The post Point Solution Fatigue? Zooming Out to the Population Level Can Help appeared first on MedCity News.

Healthcare 110

Healthcare Healthcare Patients 110

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

OCTOBER 8, 2024

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a new positive readout can return Keytruda to glory in head and neck cancer about two years after a prior failure.

287

287

Integrity Solutions

OCTOBER 8, 2024

Building rapport in sales is essential for establishing trust and fostering long-term relationships with clients. While technology has made it easier than ever for buyers to access information, B2B buyers in particular are looking for insights and advice from a salesperson they can trust and who they believe has their best interests in mind to help them make good decisions.

Sales 107

Sales Prospecting Sales process Leads 107

pharmaphorum

OCTOBER 8, 2024

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.

Sales 105

Sales Marketing Patients 105

Fierce Pharma

OCTOBER 8, 2024

With the U.S. | The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in prices. Still, that approach could affect market dynamics outside the U.S.

Marketing 218

Marketing 218

MedCity News

OCTOBER 8, 2024

When AI is directly integrated into the EHR it not only improves efficiency but also ensures that patient data remains secure within the same trusted system. The post EHRs Are Overloading Mental Health Clinicians — Can AI Save the Day? appeared first on MedCity News.

Patients 106

Patients Healthcare Healthcare 106

Fierce Pharma

OCTOBER 8, 2024

The neuroscience sector has seen a surge in investment over the past year, leading to breakthroughs and high-stakes dea | This week on "The Top Line," Fierce Pharma's Fraiser Kansteiner chats with industry leaders about the surge in neuroscience investment, breakthroughs and future targets in neuropharmaceuticals.

Pharma 144

Pharma Leads 144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

OCTOBER 8, 2024

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS in draft guidance

106

106

MedCity News

OCTOBER 8, 2024

Astellas secured an exclusive option to license global rights to an AviadoBio gene therapy in development as a one-time treatment for a certain type of frontotemporal dementia. A Phase 1/2 test of the AviadoBio gene therapy is ongoing. The post Another Astellas Gene Therapy Deal, This Time $50M for Option on AviadoBio Dementia Program appeared first on MedCity News.

Biopharma 97

Biopharma Pharma 97

Pharmaceutical Technology

OCTOBER 8, 2024

The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and cirrhosis.

98

98

pharmaphorum

OCTOBER 8, 2024

Biogen teams up with Talkiatry on telehealth programme for postpartum depression that could help drive sales of Zurzuvae

Sales 103

Sales 103

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTech

OCTOBER 8, 2024

Pharmaceutical Technology® Europe sat down with Álvaro Nocete Díaz, Pharma Division Manager at HTBA, about the benefits of flavonoids and their use in the pharmaceutical industry.

Pharmaceutical 69

Pharmaceutical Pharma Management 69

pharmaphorum

OCTOBER 8, 2024

Astellas adds a gene therapy for frontotemporal dementia to its pipeline, via a $2.2bn+ option deal with UK biotech AviadoBio.

98

98

PharmaTimes

OCTOBER 8, 2024

Real-world studies show effectiveness of mogamulizumab in routine practice

95

95

pharmaphorum

OCTOBER 8, 2024

AstraZeneca and Owkin form alliance to develop an AI tool to pre-screen breast cancer patients for BRCA mutations from digital pathology slides.

Patients 89

Patients 89

Advertisement

PharmExec

OCTOBER 8, 2024

Under terms of the deal, Astellas will obtain the license for the global development and commercialization of AVB-101 to treat frontotemporal dementia with progranulin mutations.

52

52

pharmaphorum

OCTOBER 8, 2024

J&J's TAR-200 drug fails a phase 3 bladder cancer trial, but the company is still confident in the blockbuster potential of the programme

74

74

PharmaTech

OCTOBER 8, 2024

The introduction of Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Manufacturing 52

Manufacturing 52

Pharma Marketing Network

OCTOBER 8, 2024

In an ever-evolving industry like healthcare, building a robust brand strategy is no longer optional but essential for pharma marketers. The dynamic landscape demands a comprehensive approach that not only elevates brand visibility but also fosters trust and credibility among consumers. As healthcare continues to integrate with technology, pharma marketers must navigate these changes adeptly to develop a winning healthcare brand strategy.

Healthcare 52

Healthcare Healthcare Marketing Pharma 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

ALULA

OCTOBER 8, 2024

Unlock Your Mental Potential This National Train Your Brain Day We've all heard "use it or lose it" when it comes to physical fitness, but did you know your brain follows the same principle? Just as you train your muscles, you can train your brain.

Training 52

Training 52

Pharmaceutical Technology

OCTOBER 8, 2024

In this issue: The manufacturing shift to meet growing cell and gene therapy demand, applying lessons from the Covid-19 pandemic to address mpox, a ten-year review of Opdivo and Keytruda, and more.

Manufacturing 52

Manufacturing 52

PharmaTech

OCTOBER 8, 2024

Stacey Treichler, senior director of global marketing and strategy, Purolite, an Ecolab company, spoke about current trends in the biopharma industry and innovations in purification resins at CPHI Milan.

Biopharma 52

Biopharma Marketing 52

Pharmaceutical Commerce

OCTOBER 8, 2024

With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.

Manufacturing 52

Manufacturing 52

Advertisement

Distribution

PharmExec

OCTOBER 8, 2024

Breakthrough Therapy designation for survodutide was based on preliminary clinical data showing potential improvement in patients with non-cirrhotic metabolic dysfunction-associated steatohepatitis over existing therapies.

FDA 52

FDA Patients 52

PM360

OCTOBER 8, 2024

First of its kind, in-office, digital hub enhances provider efficiency and care team collaboration Cincinnati, Ohio – October 7, 2024 – PatientPoint® a leading digital health company, today showcased the transformation of its healthcare professional solution with the launch of an interactive, in-office digital hub. This new platform delivers specialty-specific, customizable content and practice tools that empower clinicians, streamline workflows, and enhance collaboration across care teams.

Healthcare Provider 52

Healthcare Provider Pharma Rep Pharma reps Physicians 52

European Pharmaceutical Review

OCTOBER 8, 2024

CPHI Milan, the premier international pharmaceutical event, will be held from 8 to 10 October 2024 at Fiera Milano, Italy. Continuing its tradition of excellence, this year’s event aims to bring together suppliers, innovators, and professionals in pharmaceuticals within a unique environment that merges in-person and digital experiences. CPHI fosters connections and encourages partnerships within the global pharmaceutical community.

Pharma 52

Pharma Manufacturing Pharmaceutical Management 52

PM360

OCTOBER 8, 2024

Veteran safety & PV leader Adam Sherlock will capitalize on Qinecsa’s deep domain expertise and comprehensive technology-powered solutions to pharma’s most complex product safety challenges London, UK – October 8th, 2024 – Qinecsa , the global, class leader in technology-powered pharmacovigilance services, has announced the appointment of life sciences safety services mover and shaker Adam Sherlock as its new CEO, spearheading a major new growth phase for the company.

Leads 52

Leads Safety Biopharma Management 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales